ARQT Earnings Arcutis Biotherapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–26 of 26
| Q2 2026 | 2026-06-30 | 0.03 | 2026-08-05 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.09 | 2026-05-06 | 10-Q |
| FY 2025 | 2025-12-31 | -0.13 | 2026-02-25 | 10-K |
| Q3 2025 | 2025-09-30 | -0.26 | 2025-10-28 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.32 | 2026-08-05 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.20 | 2026-05-06 | 10-Q |
| FY 2025 | 2024-12-31 | -1.16 | 2026-02-25 | 10-K |
| Q3 2025 | 2024-09-30 | -1.08 | 2025-10-28 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.75 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.32 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | -3.78 | 2026-02-25 | 10-K |
| Q3 2024 | 2023-09-30 | -3.19 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.46 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.31 | 2024-05-14 | 10-Q |
| FY 2024 | 2022-12-31 | -5.66 | 2025-02-25 | 10-K |
| Q3 2023 | 2022-09-30 | -4.52 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.58 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.27 | 2023-05-09 | 10-Q |
| FY 2023 | 2021-12-31 | -4.18 | 2024-02-27 | 10-K |
| Q3 2022 | 2021-09-30 | -2.75 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.60 | 2022-08-04 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.76 | 2022-05-05 | 10-Q |
| FY 2022 | 2020-12-31 | -3.80 | 2023-02-28 | 10-K |
| Q3 2021 | 2020-09-30 | -3.06 | 2021-11-04 | 10-Q |
| Q2 2021 | 2020-06-30 | -2.05 | 2021-08-05 | 10-Q |
| FY 2021 | 2019-12-31 | -22.78 | 2022-02-22 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.